Dyne Therapeutics DYN
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 23.56 | 108.45 | -0.88 | -97,108 | -90 | |
| 2024Q3 | 35.92 | 108.79 | -0.98 | -105,659 | -97 | |
| 2024Q2 | 35.29 | 110.54 | -0.70 | -71,962 | -65 | |
| 2024Q1 | 28.39 | 105.34 | -0.81 | -69,157 | -66 | |
| 2023Q4 | 13.30 | 101.58 | -1.09 | -67,688 | -67 | |
| 2023Q3 | 8.96 | 103.43 | -0.98 | -62,274 | -60 | |
| 2023Q2 | 11.25 | 102.83 | -1.10 | -66,736 | -65 | |
| 2023Q1 | 11.52 | 102.89 | -0.78 | -45,464 | -44 | |
| 2022Q4 | 11.59 | 103.39 | -0.73 | -40,145 | -39 | |
| 2022Q3 | 12.70 | 102.16 | -0.80 | -42,280 | -41 | |
| 2022Q2 | 6.87 | 100.86 | -1.01 | -52,754 | -52 | |
| 2022Q1 | 9.64 | 100.56 | -0.69 | -35,783 | -36 | |
| 2021Q4 | 11.89 | 100.34 | -1.01 | -51,960 | -52 | |
| 2021Q3 | 16.24 | 100.43 | -0.83 | -42,767 | -43 | |
| 2021Q2 | 21.04 | 100.70 | -0.59 | -30,164 | -30 | |
| 2021Q1 | 15.53 | 100.66 | -0.50 | -25,134 | -25 | |
| 2020Q4 | 21.00 | 100.11 | 3.38 | -28,600 | -29 | |
| 2020Q3 | 20.19 | 98.04 | -1.20 | -13,519 | -14 | |
| 2020Q2 | -0.22 | -8,675 | -9 | |||
| 2020Q1 | -0.62 | -7,853 | -8 |
